Enabling innovation and access to health technologies remains a key strategy in combating infectious diseases in low- and middle-income countries (LMICs).
The traditional approach to tackling infectious diseases of poverty has been a disease-centred one but now, to benefit effectively from innovative products and use the tools needed to beat such diseases, the approach must be systems and people centred. Here at Cambridge our researchers are investing in interdisciplinary collaboration to examine integration of health innovation within national innovation systems and products and tools which are translatable across government sectors and organization levels.
Explore Campus
The Diagnostics Development Unit in the Department of Haematology is focused on developing low cost diagnostic tests for infectious diseases in the developing world.
The Analytical Biotechnology Group in the Department of Chemical Engineering and Biotechnology aims at understanding how biology can be interfaced with electronic, mechanical and optical systems and the development of new instrumentation or techniques to answer fundamental and applied questions concerning new biological measurement regimes.